feed,title,long_url,short_url
Benzinga,"Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session",https://benzinga.com/news/22/09/29058625/why-prothena-corporation-shares-are-trading-higher-by-76-here-are-53-stocks-moving-in-wednesdays-mid,https://bit.ly/3RgeRUx
Benzinga,MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders,https://benzinga.com/general/biotech/22/09/29055591/maxcyte-inks-platform-license-with-vertex-for-gene-editing-program-for-rare-blood-disorders,https://bit.ly/3fs70WG
Benzinga,"Rallybio's Thrombocytopenia Candidate Shows Rapid, Complete Elimination Of Transfused Platelets",https://benzinga.com/general/biotech/22/09/29054559/rallybios-thrombocytopenia-candidate-shows-rapid-complete-elimination-of-transfused-platelets,https://bit.ly/3ReSMpu
Benzinga,SAB Biotherapeutics Unveils New Data From COVID-19 Programs Reinforcing Efficacy Against Variants,https://benzinga.com/general/biotech/22/09/29054020/sab-biotherapeutics-unveils-new-data-from-covid-19-programs-reinforcing-efficacy-against-variants,https://bit.ly/3xZ3I3A
Benzinga,DocuSign Goes Aggressive On Cost Cuts Within A Week Of Naming Its New Chief,https://benzinga.com/news/22/09/29053231/docusign-goes-aggressive-on-cost-cuts-within-a-week-of-naming-its-new-chief,https://bit.ly/3BQzEID
